• Latest Posts

The Billion-Euro European Biotech Companies in 2022

In Depth 23 Dec 2020

Humble Beginnings: The Origin Story of Modern Biotechnology

Covid-19 Leaves Lasting Impact on Hematology at ASH 2020 Conference

Top 10 Biotech Companies Leaving a Mark in Munich

MorphoSys and Galapagos’ Eczema Drug Abandoned at Phase II

Can MorphoSys’ Alzheimer’s Treatment Work Where Big Pharma has Failed?


Morphosys and Galapagos Announce Positive Phase I Results for Atopic Dermatitis Treatment

In Depth 23 Jan 2018

Walking with the Dinosaurs of European Biotech: Which of Them is Roaring the Loudest?

Janssen’s Psoriasis Drug is Given a Thumbs Up for Use in Europe